Year: 2023

340B Stakeholders Weigh in on HRSA’s Proposal to Replace 340B Dispute Resolution Process

In Federal, RegulatoryFebruary 7, 2023367 Views

340B contract pharmacy loomed large in stakeholders’ comments on HRSA's proposed revamp of the 340B program’s administrative dispute resolution system.

The fight over 340B contract pharmacy loomed large in stakeholders’ comments last week on a proposed federal regulation to revamp the 340B program’s administrative dispute resolution system.

Health care provider groups, citing manufacturers’ contract pharmacy policies, said they

…

340B Hospital Physician Affiliated with Free-Market Think Tank Says Abolishing 340B Should be on the Table in Health Affairs Essay

In Research/ReportsFebruary 7, 2023495 Views

Ted Slafsky

“Consideration could be given to abolishing" the 340B program, Dr. Anthony DiGiorgio of Zuckerberg San Francisco General Hospital and Trauma Center writes in the policy journal Health Affairs. DiGiorgio says he receives funding from a free-market think tank "on Medicaid and access to care issues."

A neurosurgeon at a San Francisco 340B hospital who once was a health policy fellow for U.S. Sen. Bill Cassidy (R-La.) and who is doing research for a free-market oriented think tank has written a stinging reply to

…

Bernie Sanders Officially Named Chair and Bill Cassidy Ranking Republican of Senate HELP Panel

In Federal, LegislativeFebruary 7, 2023161 Views

Laura Gilcrest

Sen. Bernie Sanders (I-Vt.) (left), is the new chair of the Senate HELP Committee and Sen. Bill Cassidy (R-La.) is its new ranking Republican.

The U.S. Senate committee with jurisdiction over 340B is officially under new leadership, with Bernie Sanders (I-Vt.) being seated as Health, Education, Labor, and Pensions chair last week and Bill Cassidy (R-La.) as ranking Republican.

The formal announcements

…

GSK Announces Refunds for 340B Overcharges on Respiratory Drugs

In Federal, Pharma Industry, RegulatoryFebruary 7, 2023122 Views

Laura Gilcrest

GlaxoSmithKline said last week it would pay refunds for 340B overcharges occurring in Q1 2021.

Pharmaceutical manufacturer GlaxoSmithKline said last week it would pay refunds for 340B overcharges occurring in the first quarter of 2021, including overcharges for blockbuster respiratory drugs Trelegy and Nucala.

The refund notice posted Feb. 2 on the

…

340B INDUSTRY LEADER SPOTLIGHT

Andrew Crawford, Senior Vice President, Business Development, Maxor National Pharmacy Services

In Industry Leader Spotlight, Sponsored ContentFebruary 7, 20231785 Views

Diane Slafsky

Q: Where did you grow up?

In Macon, GA, primarily (that is where I graduated high school)

Q: Where did you go to college?

Washington and Lee University

…

Drugmakers Urge Appeals Courts to Follow Third Circuit Ruling and Uphold 340B Contract Pharmacy Restrictions

In Federal, JudicialFebruary 2, 2023516 Views

Laura Gilcrest

Lilly, Novartis, and United Therapeutics want the appeals courts hearing their 340B contract pharmacy cases to follow the lead of the appeals court in AstraZeneca, Sanofi, and Novo Nordisk’s cases and uphold their 340B policies.

Drugmakers Lilly, Novartis, and United Therapeutics this week urged federal appeals courts in Chicago and Washington, D.C., to follow the lead of the appeals court in Philadelphia and uphold their restrictions on 340B providers’ use of contract pharmacies.

…

Bayer: 340B “Is Enriching Middlemen Versus Benefitting Patients”

In Pharma IndustryFebruary 2, 2023462 Views

Tom Mirga

The 340B program has “strayed far from its original purpose, creating a profit stream that is enriching middlemen versus benefiting patients,” Bayer says.

While the 340B program “has merit when used as intended,” it has “strayed far from its original purpose, creating a profit stream that is enriching middlemen versus benefitting patients,” drug manufacturer Bayer told 340B Report yesterday.

Bayer gave

…

The Potential Domino Effect of Tennessee’s HIV Federal Funding Cuts

In Sponsored ContentFebruary 2, 2023730 Views

Upcoming End of COVID-19 Emergency Could Prompt HRSA to End or Scale Back 340B Flexibilities

In Federal, RegulatoryFebruary 2, 2023298 Views

Tom Mirga

The Biden administration plans to end the nationwide COVID-19 public health emergency on May 11.

The Biden administration said on Monday that it plans to end the nationwide COVID-19 public health emergency on May 11. When the PHE ends, COVID-related 340B program flexibilities announced in March 2020 could end too.

The U.S. Health

…

AHA Seeks Meeting with HHS About Repaying 340B Hospitals for Illegal Medicare Drug Reimbursement Cuts

In Federal, Judicial, RegulatoryFebruary 2, 2023114 Views

Tom Mirga

The AHA wants to meet with HHS to hear how the government will repay 340B hospitals for five years’ worth of illegal Medicare Part B drug reimbursement cuts.

The American Hospital Association yesterday asked to meet with the team of federal officials that will decide how the government will repay 340B hospitals for five years’ worth of illegal Medicare Part B drug reimbursement cuts. The amount

…